The source told the agency that the project was being implemented by the state joint-stock concern Uzfarmsanoat together with the world leader in the production of anti-flu medicines - the Hungarian company Omninvest.

"There are plans to start production at the new plant at the end of 2010. However, doctors in Central Asia will get a vaccine made by the company as early as this autumn: during the construction of the plant, the medicine will be supplied from Hungary," the press service official explained.